Buy Or Sell Opportunity • Jul 01
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 26% to US$17.99. The fair value is estimated to be US$14.62, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 44% over the last year. Meanwhile, the company has become profitable. Revenue is forecast to grow by 8.3% in a year. Earnings are forecast to grow by 16% in the next year. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to US$15.93, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Insurance industry in the US. Simply Wall St's valuation model estimates the intrinsic value at US$14.62 per share. Canlı Haberler • Jun 13
Exzeo Group Authorizes US$12 Million Buyback and Expands Carrier Partnerships After Q1 Recognition Exzeo Group, Inc. has been listed among the “10 Best Insurance Stocks to Buy Following Q1 Earnings” by a recent research piece.
On May 26, the Board of Directors authorized a new share repurchase program for up to US$12 million of the company’s common stock.
The company reported continued momentum across its platform, including growth in managed premiums and the addition of a seventh insurance carrier partner.
Being included in a focused insurance stock list, alongside the new buyback authorization and added carrier partner, points to a company working to strengthen both its operating platform and its capital deployment approach.
You may want to pay attention to how quickly Exzeo uses the repurchase capacity and whether managed premium trends and carrier relationships continue to support scale in the business model. Canlı Haberler • May 27
Exzeo Group Approves Up To $12 Million Share Buyback Reflecting Confidence in Long-Term Value Exzeo Group’s board authorized a new stock repurchase program of up to $12 million of common shares.
The buyback will be executed under Rule 10b5-1, which allows purchases to continue during trading blackout periods.
Management linked the decision to confidence in Exzeo’s long-term value and its current cash flow position.
The key signal here is that the board is willing to allocate capital to equity repurchases. This usually reflects a view that the current share price is an acceptable use of cash relative to other options such as debt reduction or internal investment.
It is still important to watch how quickly the company actually uses the $12 million authorization, since the wording makes clear that execution depends on market conditions and the program may not be fully completed. Duyuru • May 26
Exzeo Group, Inc. (NYSE:XZO) announces an Equity Buyback for $12 million worth of its shares. Exzeo Group, Inc. (NYSE:XZO) announces a share repurchase program. Under the program, the company will repurchase up to $12 million worth of its shares. Valuation Update With 7 Day Price Move • May 14
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to US$13.38, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Insurance industry in the US. Simply Wall St's valuation model estimates the intrinsic value at US$14.62 per share. Reported Earnings • May 07
First quarter 2026 earnings released: EPS: US$0.22 (vs US$0.22 in 1Q 2025) First quarter 2026 results: EPS: US$0.22 (up from US$0.22 in 1Q 2025). Revenue: US$58.0m (up 9.9% from 1Q 2025). Net income: US$19.8m (up 16% from 1Q 2025). Profit margin: 34% (up from 32% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Insurance industry in the US. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$17.50, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 10x in the Insurance industry in the US. Simply Wall St's valuation model estimates the intrinsic value at US$11.78 per share. Duyuru • Apr 14
Exzeo Group, Inc. to Report Q1, 2026 Results on May 06, 2026 Exzeo Group, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026 Duyuru • Apr 10
Exzeo Group, Inc., Annual General Meeting, Jun 09, 2026 Exzeo Group, Inc., Annual General Meeting, Jun 09, 2026. Location: 1000 century park drive, tampa, florida, United States Buy Or Sell Opportunity • Mar 31
Now 25% overvalued Over the last 90 days, the stock has fallen 40% to US$14.67. The fair value is estimated to be US$11.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 40% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 36% in the next 2 years. Reported Earnings • Feb 28
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: US$0.99 (up from US$0.19 in FY 2024). Revenue: US$221.3m (up 65% from FY 2024). Net income: US$82.7m (up 463% from FY 2024). Profit margin: 37% (up from 11% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 3.1% growth forecast for the Insurance industry in the US. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to US$17.50, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 11x in the Insurance industry in the US. Simply Wall St's valuation model estimates the intrinsic value at US$10.77 per share. Duyuru • Feb 05
Exzeo Group, Inc. to Report Q4, 2025 Results on Feb 25, 2026 Exzeo Group, Inc. announced that they will report Q4, 2025 results After-Market on Feb 25, 2026 Recent Insider Transactions • Dec 23
President & Director recently bought US$245k worth of stock On the 18th of December, Kevin Mitchell bought around 13k shares on-market at roughly US$19.58 per share. This transaction amounted to 1.8% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth US$1.1m. Kevin has been a buyer over the last 12 months, purchasing a net total of US$266k worth in shares. Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to US$23.19, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 15x in the Software industry in the US. Simply Wall St's valuation model estimates the intrinsic value at US$10.31 per share. Reported Earnings • Dec 11
Third quarter 2025 earnings: EPS exceeds analyst expectations Third quarter 2025 results: EPS: US$0.25. Revenue: US$56.3m (up 52% from 3Q 2024). Net income: US$21.2m (up US$21.2m from 3Q 2024). Profit margin: 38% (up from 0% in 3Q 2024). The increase in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.2%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Software industry in the US. Buy Or Sell Opportunity • Dec 10
Now 21% overvalued The stock has been flat over the last 90 days, currently trading at US$17.45. The fair value is estimated to be US$14.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last year. Meanwhile, the company has become profitable. Revenue is forecast to grow by 39% in 2 years. Earnings are forecast to grow by 84% in the next 2 years. Duyuru • Nov 26
Exzeo Group, Inc. to Report Q3, 2025 Results on Dec 10, 2025 Exzeo Group, Inc. announced that they will report Q3, 2025 results After-Market on Dec 10, 2025 Valuation Update With 7 Day Price Move • Nov 20
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to US$14.59, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 30x in the Software industry in the US. Recent Insider Transactions • Nov 09
CEO & Chairman recently bought US$1.1m worth of stock On the 6th of November, Pareshbhai Patel bought around 50k shares on-market at roughly US$21.00 per share. This transaction amounted to 3.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Pareshbhai's only on-market trade for the last 12 months. Board Change • Nov 05
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Independent Director Bob Lopes was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Nov 05
Exzeo Group, Inc. has completed an IPO in the amount of $168 million. Exzeo Group, Inc. has completed an IPO in the amount of $168 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 8,000,000
Price\Range: $21
Discount Per Security: $1.47
Transaction Features: Reserved Share Offering; Sponsor Backed Offering